KORU Medical Systems, Inc. (NASDAQ:KRMD)

Thursday, March 13, 2025 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($3.28; $150.3M market cap), announced Q4 2024 results: Q4...
Monday, January 13, 2025 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($3.96; $181.9M market cap), announced preliminary Q4 2024 results: Preliminary,...
Thursday, March 14, 2024 | Web News
KORU Medical Systems (NASDAQ:KRMD) ($2.12; $96.8M market cap), announced Q4 2023 results: Q4 sales of...
See All Research...
Tuesday, October 7, 2014, 9:25 AM
Repro-Med Systems' Focus On The Home-Care Market Could Lead To Substantial Payoff Or Buyout
See All Articles and Reports...
Tuesday, August 11, 2026, 10:52 AM
Summer 2026 Virtual Conference Highlights: 10 Company Presentations, 6 Investor Pitches & an AI Memory Roundtable [GeoWire Weekly No. 251]
Sunday, May 10, 2026, 1:18 PM
NEW Model Portfolio Addition: A Stock Selling At A P/E Of Less Than 10x That Meets All Ten Of Our Quality Factors [GeoWire Weekly No. 238] | Long-Term vs. Short-Term Debate
Sunday, March 15, 2026, 12:27 PM
New Research: Medical Device Company with 200% Upside; Information Arbitrage On OCC TSSI BIRDF [GeoWire Weekly No. 230]
See All GeoWire Weekly...
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60(R) and FreedomEdge(R) Syringe Infusion Drivers, Precision Flow Rate Tubing(TM) and HIgH-Flo Subcutaneous Safety Needle Sets(TM) . These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Web site: http://www.repro-med.com

Last updated November 1, 2019


Market Data powered by QuoteMedia. Terms of Use